ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,161.89
      0.67%
      US Tech 100
      17,525.00
      0.61%
      Dow Jones
      38,796.11
      0.31%
      Brent Oil
      83.075
      -0.06%
      Bitcoin
      62,987.92
      -1.58%
      Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Astria Therapeutics Inc (ATXS)

      7. Astria Therapeutics Inc (ATXS) News

      ATXS

      Astria Therapeutics (ATXS)

      Astria Therapeutics Inc
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:ATXS
      DateTimeSourceHeadlineSymbolCompany
      05/02/20244:00PMBusiness WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
      04/09/20248:00AMBusiness WireAstria Therapeutics Appoints Sunil Agarwal to Its Board of DirectorsNASDAQ:ATXSAstria Therapeutics Inc
      04/03/20244:10PMBusiness WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
      03/25/20247:30AMBusiness WireAstria Therapeutics Announces Positive Initial Proof-of-Concept Results from the ALPHA-STAR Phase 1b/2 Trial of STAR-0215 for HAENASDAQ:ATXSAstria Therapeutics Inc
      03/05/20244:10PMBusiness WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
      03/04/20245:22PMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATXSAstria Therapeutics Inc
      03/04/20245:20PMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ATXSAstria Therapeutics Inc
      03/04/20244:10PMBusiness WireAstria Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate UpdateNASDAQ:ATXSAstria Therapeutics Inc
      03/04/20244:02PMEdgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:ATXSAstria Therapeutics Inc
      02/20/20248:00AMBusiness WireAstria Therapeutics to Present at Upcoming American Academy of Allergy, Asthma & Immunology Annual MeetingNASDAQ:ATXSAstria Therapeutics Inc
      02/14/20243:48PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
      02/14/20243:00PMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
      02/14/20248:36AMEdgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:ATXSAstria Therapeutics Inc
      02/12/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
      02/12/20244:06PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
      02/12/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
      02/12/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
      02/12/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
      02/12/20244:05PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
      02/06/20248:00AMBusiness WireAstria Therapeutics to Present at Upcoming Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:ATXSAstria Therapeutics Inc
      02/05/20244:00PMBusiness WireAstria Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:ATXSAstria Therapeutics Inc
      01/31/20249:00AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATXSAstria Therapeutics Inc
      01/31/20248:59AMEdgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:ATXSAstria Therapeutics Inc
      01/30/20245:03PMEdgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:ATXSAstria Therapeutics Inc
      01/30/20249:08AMBusiness WireAstria Therapeutics Announces Pricing of $125 Million Underwritten OfferingNASDAQ:ATXSAstria Therapeutics Inc
      01/30/20246:01AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATXSAstria Therapeutics Inc
      01/29/20244:39PMEdgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:ATXSAstria Therapeutics Inc
      01/16/20244:18PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ATXSAstria Therapeutics Inc
      01/05/20248:30AMEdgar (US Regulatory)Form 8-K - Current reportNASDAQ:ATXSAstria Therapeutics Inc
      01/02/20244:16PMEdgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:ATXSAstria Therapeutics Inc
       Showing the most relevant articles for your search:NASDAQ:ATXS